Holzer & Holzer, LLC has filed a securities class against lawsuit against Emergent BioSolutions, Inc. (NYSE: EBS). Investors who wish to file a motion to become the lead plaintiff in the litigation must do so not later than September 19, 2016.

The lawsuit alleges, among other things, that the Company overstated demand for its anthrax vaccine between January 11, 2016 and June 21, 2016.

If you purchased Emergent BioSolutions common stock between those dates and suffered a significant loss on that investment, you are encouraged to contact Holzer & Holzer attorneys Corey D. Holzer, Esq. at cholzer@holzerlaw.com or Marshall P. Dees, Esq., at mdees@holzerlaw.com, or via toll-free telephone at (888) 508-6832, to discuss your legal rights.

Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.

Holzer & Holzer, LLCCorey D. Holzer, Esq., 888-508-6832 (toll-free)cholzer@holzerlaw.com

Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Emergent Biosolutions Charts.
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Emergent Biosolutions Charts.